Manjit Rahelu, the chief business officer of Arecor Therapeutics PLC (AIM:AREC), elaborates on the company s latest milestone. This development involves a.
Arecor list in London and look forward to delivering on exciting next phase of growth
Arecor Therapeutics (LON:AREC) CEO Sarah Howell joins Proactive London on the first day of their London listing. The firm has raised £20 million in the oversubscribed IPO, receiving strong support from investors.
Howell explains what the money will be used for, progressing their lead diabetes products as well as developing and expanding their pipeline of specialty hospital ready-to-use and ready-to-administer products.
Quick facts: Arecor Therapeutics PLC
Follow